| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $411.3M | +14.7% |
| Gross Profit | $307.7M | +3.9% |
| R&D Expense | $30.6M | +124.1% |
| SG&A Expense | $113.3M | -2.1% |
| Operating Income | $163.7M | -1.9% |
| Interest Expense | $16.7M | -24.8% |
| Pre-tax Income | $326.9M | +774.2% |
| Income Tax | $55.7M | +297.9% |
| Net Income | $271.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $550.9M | +80.7% |
| Inventory | $39.2M | +16.2% |
| Current Assets | $727.5M | +31.2% |
| Total Assets | $1.64B | +25.7% |
| Current Liabilities | $49.7M | -78.9% |
| Long-term Debt | $257.7M | +0.6% |
| Stockholders' Equity | $1.17B | +69.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $196.9M | +4.4% |
| Capital Expenditures | $1.1M | +318.9% |
| Investing Cash Flow | $40.5M | +163.5% |
| Financing Cash Flow | $8.6M | +163.6% |
| Free Cash Flow | $195.8M | +3.9% |
| +1059.2% |
| EPS (Basic) | $4.02 | +986.5% |
| EPS (Diluted) | $3.30 | +816.7% |